New Products

Cat. No.	Product Name	Target	Research Area	Added	Chemical Structure

HY-W141820	Fmoc-Phe(bis-Boc-4-guanidino)-OH	Amino Acid Derivatives	Others	2025-01
HY-P10441A	S-palm P0(180–199) TFA	Others	Inflammation/Immunology	2025-01
HY-W009401	Boc-Ala(4-pyridyl)-OH	Amino Acid Derivatives	Others	2025-01
HY-P990894	Anti-DM1 antibody(14E3) (Rabbit mAb)	Microtubule/Tubulin; ADC Cytotoxin	Cancer	2025-01
HY-150523S	Sodium borodeuteride-d4	Others	Others	2025-01
HY-P10782	Pt(IV)-M13	Peptide-Drug Conjugates (PDCs)	Cancer	2025-01
HY-121735	2α-Mannobiose	Biochemical Assay Reagents	Others	2025-01
HY-171013	THR-β agonist 8	Thyroid Hormone Receptor	Metabolic Disease; Neurological Disease	2025-01
HY-N10479	Chorismic acid	Endogenous Metabolite	Metabolic Disease	2025-01
HY-171006	IRF1-IN-1	Caspase; PARP; Pyroptosis; Interleukin Related; IFNAR	Infection; Inflammation/Immunology	2025-01
HY-153856	TAS2940	EGFR	Cancer	2025-01
HY-159798	NR-11c	PROTACs; p38 MAPK	Cancer	2025-01
HY-P3006	Des-Leu10-angiotensin I	Drug Metabolite	Cardiovascular Disease	2025-01
HY-170515	RNF5 agonist 1	E1/E2/E3 Enzyme	Inflammation/Immunology	2025-01
HY-170526	ERK2 IN-5	ERK; JNK	Cancer	2025-01
HY-171030	Pro-GA	Ferroptosis	Cancer	2025-01
HY-164955	TTK/PLK1-IN-1	Mps1; Polo-like Kinase (PLK)	Cancer	2025-01
HY-W141907	Fmoc-N-(4-Boc-aminobutyl)-Gly-OH	Amino Acid Derivatives	Others	2025-01
HY-118796	4-Hydroxy MET	5-HT Receptor	Neurological Disease	2025-01
HY-170033	3-Carboxamidonaltrexone	Opioid Receptor	Neurological Disease	2025-01

Name
Email *

	Sorry, but the email address you supplied was invalid.